A detailed history of Apg Asset Management N.V. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Apg Asset Management N.V. holds 117,431 shares of EW stock, worth $7.96 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
117,431
Previous 492,537 76.16%
Holding current value
$7.96 Million
Previous $45.5 Million 82.97%
% of portfolio
0.05%
Previous 0.08%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$59.7 - $93.78 $22.4 Million - $35.2 Million
-375,106 Reduced 76.16%
117,431 $7.75 Million
Q2 2024

Aug 14, 2024

BUY
$84.3 - $94.31 $1.17 Million - $1.3 Million
13,832 Added 2.89%
492,537 $45.5 Million
Q1 2024

May 14, 2024

BUY
$72.54 - $95.56 $2.31 Million - $3.05 Million
31,890 Added 7.14%
478,705 $45.7 Million
Q4 2023

Feb 13, 2024

SELL
$61.71 - $77.76 $1.4 Million - $1.76 Million
-22,638 Reduced 4.82%
446,815 $34.1 Million
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $4.47 Million - $6.02 Million
-64,465 Reduced 12.07%
469,453 $32.5 Million
Q2 2023

Aug 14, 2023

SELL
$81.41 - $94.33 $1.33 Million - $1.54 Million
-16,371 Reduced 2.97%
533,918 $50.4 Million
Q1 2023

May 12, 2023

SELL
$74.26 - $84.51 $7.25 Million - $8.25 Million
-97,639 Reduced 15.07%
550,289 $45.5 Million
Q4 2022

Feb 14, 2023

BUY
$68.3 - $87.44 $36.1 Million - $46.2 Million
528,087 Added 440.66%
647,928 $48.3 Million
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $1.02 Million - $1.32 Million
12,332 Added 11.47%
119,841 $10.1 Million
Q2 2022

Aug 12, 2022

BUY
$86.5 - $128.27 $2.24 Million - $3.32 Million
25,910 Added 31.75%
107,509 $9.78 Million
Q1 2022

May 12, 2022

SELL
$101.96 - $128.34 $2.82 Million - $3.56 Million
-27,700 Reduced 25.34%
81,599 $8.63 Million
Q4 2021

Feb 11, 2022

SELL
$106.37 - $130.68 $3.02 Million - $3.71 Million
-28,400 Reduced 20.62%
109,299 $12.5 Million
Q3 2021

Nov 15, 2021

BUY
$102.91 - $122.75 $174,947 - $208,675
1,700 Added 1.25%
137,699 $13.5 Million
Q2 2021

Aug 13, 2021

BUY
$83.84 - $104.76 $2.91 Million - $3.63 Million
34,680 Added 34.23%
135,999 $11.9 Million
Q1 2021

May 14, 2021

SELL
$78.68 - $90.67 $29.7 Million - $34.3 Million
-377,985 Reduced 78.86%
101,319 $7.21 Million
Q4 2020

Feb 12, 2021

SELL
$71.69 - $91.23 $6.67 Million - $8.48 Million
-93,003 Reduced 16.25%
479,304 $35.7 Million
Q3 2020

Nov 12, 2020

SELL
$67.19 - $87.44 $4.9 Million - $6.37 Million
-72,858 Reduced 11.29%
572,307 $39 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $19.3 Million - $25.9 Million
336,174 Added 108.8%
645,165 $39.7 Million
Q1 2020

May 15, 2020

BUY
$52.41 - $81.0 $12.9 Million - $19.9 Million
245,647 Added 387.8%
308,991 $58.3 Million
Q1 2020

May 14, 2020

SELL
$52.41 - $81.0 $30.5 Million - $47.1 Million
-582,047 Reduced 90.19%
63,344 $10.8 Million
Q4 2019

Feb 13, 2020

BUY
$71.7 - $82.09 $19.3 Million - $22.1 Million
269,400 Added 71.65%
645,391 $134 Million
Q3 2019

Nov 08, 2019

BUY
$61.55 - $75.43 $18.2 Million - $22.3 Million
295,847 Added 369.14%
375,991 $75.8 Million
Q2 2019

Aug 13, 2019

BUY
$55.74 - $64.41 $936,432 - $1.08 Million
16,800 Added 26.52%
80,144 $13 Million
Q1 2019

May 14, 2019

SELL
$47.89 - $64.05 $684,827 - $915,915
-14,300 Reduced 18.42%
63,344 $10.8 Million
Q4 2018

Feb 13, 2019

SELL
$46.41 - $56.94 $97,461 - $119,574
-2,100 Reduced 2.63%
77,644 $10.4 Million
Q3 2018

Nov 09, 2018

BUY
$45.7 - $58.03 $27,420 - $34,818
600 Added 0.76%
79,744 $12 Million
Q2 2018

Aug 13, 2018

SELL
$42.45 - $51.3 $246,210 - $297,540
-5,800 Reduced 6.83%
79,144 $9.87 Million
Q1 2018

May 14, 2018

SELL
$37.19 - $47.45 $29,752 - $37,960
-800 Reduced 0.93%
84,944 $9.64 Million
Q4 2017

Jan 24, 2018

BUY
$33.79 - $39.39 $652,147 - $760,227
19,300 Added 29.05%
85,744 $8.05 Million
Q3 2017

Oct 19, 2017

BUY
$36.29 - $38.83 $2.41 Million - $2.58 Million
66,444
66,444 $7.26 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Apg Asset Management N.V. Portfolio

Follow Apg Asset Management N.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management N.V. with notifications on news.